Latest Articles

Publication Date
Cartherics emerges as Asia Pacific leader in off-the-shelf immune cell therapy - BiotechDispatch

Cartherics emerges as Asia Pacific leader in off-the-shelf immune cell therapy BiotechDispatch

Published: July 2, 2026, 12:04 a.m.
Cartherics emerges as Asia Pacific leader in off the shelf immune cell therapy - PharmaDispatch

Cartherics emerges as Asia Pacific leader in off the shelf immune cell therapy PharmaDispatch

Published: July 1, 2026, 1:09 a.m.
Surgery or Hormonal Therapy for Rectovaginal Endometriosis? - Medscape

Surgery or Hormonal Therapy for Rectovaginal Endometriosis? Medscape

Published: June 30, 2026, noon
Does Surgery Outperform Hormonal Therapy for Rectovaginal Endometriosis? - Medscape

Does Surgery Outperform Hormonal Therapy for Rectovaginal Endometriosis? Medscape

Published: June 30, 2026, noon
Lilly-backed Absci banks $100m to progress endometriosis, hair loss therapy - MSN

Lilly-backed Absci banks $100m to progress endometriosis, hair loss therapy MSN

Published: June 27, 2026, 6:48 p.m.
Lilly-backed Absci banks $100m to progress endometriosis, hair loss therapy - Clinical Trials Arena

Lilly-backed Absci banks $100m to progress endometriosis, hair loss therapy Clinical Trials Arena

Published: June 26, 2026, 4:52 p.m.
Lilly-backed Absci banks $100m to progress endometriosis, hair loss therapy - Pharmaceutical Technology

Lilly-backed Absci banks $100m to progress endometriosis, hair loss therapy Pharmaceutical Technology

Published: June 26, 2026, 10:33 a.m.
Fertility-Preserving Therapy May Impair Endometrial Function and IVF Success After Endometrial Cancer:... - Medical Dialogues

Fertility-Preserving Therapy May Impair Endometrial Function and IVF Success After Endometrial Cancer:... Medical Dialogues

Published: June 19, 2026, 2:30 p.m.
Immunotherapy in dMMR/MSI-H endometrial cancer – a true game-changer? - ESMO Daily Reporter

Immunotherapy in dMMR/MSI-H endometrial cancer – a true game-changer? ESMO Daily Reporter

Published: June 18, 2026, 2:24 p.m.
Antibody therapy points to a new treatment era for primary membranous nephropathy - Drug Discovery News

Antibody therapy points to a new treatment era for primary membranous nephropathy Drug Discovery News

Published: June 16, 2026, 9:19 p.m.
Link copied to clipboard!
Subscribe to Our Newsletter

Stay updated with our latest articles!